Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

31.5K
Overview
31.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnosis of infectious diseases.

Journal of medical microbiology·2025
Same author

Erratum: The Ebola virus - going beyond the bleeding edge.

Journal of medical microbiology·2025
Same author

Respiratory virus coinfections with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) continue to be rare one year into the coronavirus disease 2019 (COVID-19) pandemic in Alberta, Canada (June 2020-May 2021).

Infection control and hospital epidemiology·2021
Same author

Broad respiratory testing to identify SARS-CoV-2 viral co-circulation and inform diagnostic stewardship in the COVID-19 pandemic.

Virology journal·2021
Same author

Clonal analysis of meningococci during a 26 year period prior to the introduction of meningococcal serogroup C vaccines.

PloS one·2015
Same author

Analysis of genetic relatedness of Haemophilus influenzae isolates by multilocus sequence typing.

Journal of bacteriology·2007

Related Experiment Video

Updated: Sep 17, 2025

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

36.4K

The Ebola virus - going beyond the bleeding edge.

Saadiya K Umar1,2, Mathew A Diggle1,2

  • 1Provincial Laboratory for Public Health (ProvLab), Alberta Precision Laboratories (APL), Alberta Health Services, Edmonton, Alberta T6G 2J2, Canada.

Journal of Medical Microbiology
|July 3, 2025
PubMed
Summary

Ebola virus disease (EVD) is a severe hemorrhagic illness caused by the Ebola virus genus, with the Zaire strain being the most virulent. EVD outbreaks, originating from bats, pose a significant public health risk due to high fatality and rapid spread.

Keywords:
Ebola virus (EBV)Ebola virus genusmortalityoutbreakviral hemorrhagic feverzoonosis

More Related Videos

Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.2K
Rapid, Safe, and Simple Manual Bedside Nucleic Acid Extraction for the Detection of Virus in Whole Blood Samples
06:59

Rapid, Safe, and Simple Manual Bedside Nucleic Acid Extraction for the Detection of Virus in Whole Blood Samples

Published on: June 30, 2018

7.5K

Related Experiment Videos

Last Updated: Sep 17, 2025

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

36.4K
Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.2K
Rapid, Safe, and Simple Manual Bedside Nucleic Acid Extraction for the Detection of Virus in Whole Blood Samples
06:59

Rapid, Safe, and Simple Manual Bedside Nucleic Acid Extraction for the Detection of Virus in Whole Blood Samples

Published on: June 30, 2018

7.5K

Area of Science:

  • Virology
  • Public Health
  • Epidemiology

Background:

  • Ebola virus disease (EVD) is a severe hemorrhagic illness caused by viruses in the Filoviridae family.
  • Five species of Ebola virus (EBV) are known causative agents, with the Zaire strain being the most virulent and predominant in outbreaks.
  • EVD outbreaks have occurred sporadically since 1976, with a recent episode in Uganda (September 2022-January 2023).

Purpose of the Study:

  • To summarize the epidemiology and characteristics of Ebola virus disease (EVD).
  • To highlight the public health implications of EVD outbreaks.
  • To underscore the need for ongoing research and surveillance.

Main Methods:

  • Literature review of EVD outbreaks and characteristics.
  • Analysis of transmission patterns and host reservoirs.
  • Summary of current treatment and research status.

Main Results:

  • EVD is a zoonotic disease with bats as reservoir hosts, transmitted through contact with infected bodily fluids.
  • The Zaire strain of EBV is the most virulent, leading to high mortality and infectivity rates.
  • Supportive care is the primary treatment, with vaccine development research underway.

Conclusions:

  • EVD represents a significant global public health concern due to its high fatality rate and potential for widespread transmission.
  • Effective surveillance and rapid response are crucial for managing EVD outbreaks.
  • Continued research into vaccines and treatments is essential to combat this deadly disease.